数える権利.

Same author

Nothing About Us Without Us: Consolidating Experiences of Maternity Care to Advance Equity.

BJOG : an international journal of obstetrics and gynaecology·2025

Same author

Accounting for stillbirths in maternal health metrics: a cross-country analysis.

EClinicalMedicine·2025

Same author

Rising to the challenge: lessons learnt from the Global Women's Research Society (GLOW) conference for women's and newborn health in the context of global crises.

Sexual and reproductive health matters·2025

Same author

Rural physicians and social capital: the potential and promises of a rural health research capacity building program.

BMC medical education·2024

Same author

Using the adaptive action method to tackle wicked problems in rural faculty development.

BMC medical education·2024

Same author

Environmental cleaning barriers and mitigation measures identified through two initiatives in four countries, 2018-2023: a commentary.

Antimicrobial resistance and infection control·2024

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

関連する実験動画

数える権利.

関連する概念動画

Nothing About Us Without Us: Consolidating Experiences of Maternity Care to Advance Equity.

Accounting for stillbirths in maternal health metrics: a cross-country analysis.

Rising to the challenge: lessons learnt from the Global Women's Research Society (GLOW) conference for women's and newborn health in the context of global crises.

Rural physicians and social capital: the potential and promises of a rural health research capacity building program.

Using the adaptive action method to tackle wicked problems in rural faculty development.

Environmental cleaning barriers and mitigation measures identified through two initiatives in four countries, 2018-2023: a commentary.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

関連する実験動画

数える権利.

関連する概念動画

関連記事

Nothing About Us Without Us: Consolidating Experiences of Maternity Care to Advance Equity.

Accounting for stillbirths in maternal health metrics: a cross-country analysis.

Rising to the challenge: lessons learnt from the Global Women's Research Society (GLOW) conference for women's and newborn health in the context of global crises.

Rural physicians and social capital: the potential and promises of a rural health research capacity building program.

Using the adaptive action method to tackle wicked problems in rural faculty development.

Environmental cleaning barriers and mitigation measures identified through two initiatives in four countries, 2018-2023: a commentary.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.